Insulin independence following islet transplantation improves long‐term metabolic outcomes
Diabetic Medicine · 2024
DOI: 10.1111/dme.15257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, 2024. Verfasst von Adam K Stanley und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1, Hypoglycemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Aims
Pancreatic islet allotransplantation is an effective therapy for type 1 diabetes mellitus, restoring glycaemic control and hypoglycaemic awareness in patients with recurrent severe hypoglycaemia. Insulin independence following transplant is being increasingly reported; however, this is not a primary endpoint in the UK. Having surpassed 10 years of islet transplantation in Scotland, we aimed to evaluate the impact of insulin independence following transplant on metabolic outcomes and graft survival.
Methods
We conducted a retrospective analysis on data collected prospectively between 2011 and 2022. Patients who underwent islet transplantation in Scotland up to the 31st January 2020 were included. Primary endpoint was graft survival (stimulated C‐peptide >50 pmol/L). Secondary endpoints included GOLD score, HbA1c, C‐peptide and insulin requirement. Outcomes were compared between patients who achieved insulin independence at any point following transplant versus those who did not.
Results
60 patients were included. 74.5% experienced >50 severe hypoglycaemic episodes in the year preceding transplant. There was a 55.0% decrease in insulin requirement following transplant and 30.0% achieved insulin independence. Mean graft survival time was 9.0 years (95% CI 7.2–10.9) in patients who achieved insulin independence versus 4.4 years (95% CI 3.4–5.3) in patients who did not. Insulin independence was associated with significantly improved graft function, glycaemic control and hypoglycaemic awareness at 1 year.
Conclusions
This is the largest UK single‐centre study on islet transplant to date. Our findings demonstrate significantly improved outcomes in patients who achieved insulin independence following islet transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
- Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK.
- Islet Cell Laboratory, Scottish National Blood Transfusion Service, Edinburgh, UK.
- BHF Centre for Cardiovascular Sciences, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
ORCID-Profile: Adam K Stanley, Shareen Forbes
Förderung
- Medical Research Council
Zitieren
APA
Stanley, A. K., Duncan, K., Anderson, D., Irvine, L., Sutherland, A., Forbes, S., & Casey, J. (2024). Insulin independence following islet transplantation improves long‐term metabolic outcomes. Diabetic Medicine. https://doi.org/10.1111/dme.15257
Vancouver
Stanley AK, Duncan K, Anderson D, Irvine L, Sutherland A, Forbes S, et al. Insulin independence following islet transplantation improves long‐term metabolic outcomes. Diabetic Medicine. 2024. doi:10.1111/dme.15257
BibTeX
@article{Stanley2024,
author = {Stanley, Adam K and Duncan, Kirsty and Anderson, Debbie and Irvine, Lora and Sutherland, Andrew and Forbes, Shareen and Casey, John},
title = {Insulin independence following islet transplantation improves long‐term metabolic outcomes},
journal = {Diabetic Medicine},
year = {2024},
doi = {10.1111/dme.15257}
}
EUVIMED